BILL ANALYSIS                                                                                                                                                                                                    �



                                                                  ACR 51
                                                                  Page  1

          CONCURRENCE IN SENATE AMENDMENTS
          ACR 51 (Perea)
          As Amended June 29, 2011
          Majority vote
           
           ----------------------------------------------------------------- 
          |ASSEMBLY:  |     |(May 19, 2011)  |SENATE: |39-0 |(July 7, 2011) |
           ----------------------------------------------------------------- 
                (adopted by unanimous vote)

          Original Committee Reference:    RLS.

          SUMMARY :  Proclaims the month of May 2011 as Neurofibromatosis 
          Awareness Month to educate the public about this common genetic 
          disorder. 

           The Senate amendment  adds a co-author.

           AS PASSED BY THE ASSEMBLY  , the resolution made the following 
          legislative findings:

          1)Neurofibromatosis (NF) is a neurological disorder affecting 
            one in every 3,000 births; and, it affects people of all races 
            and ethnicities, and both sexes equally.  

          2)The Children's Tumor Foundation is the leader in research 
            aimed at finding effective treatments and the cure for NF; 
            and, the foundation is working to improve the quality of 
            patient care and family support.

          3)Research has linked NF to cancer, brain tumors, memory loss, 
            learning disabilities, heart disease, blindness, deafness, and 
            orthopedic problems; and, since locating the genes that cause 
            NF in the 1990s, researchers have made progress in 
            understanding the disorder and creating drugs to combat it.

          4)Increasing public awareness of NF may bring hope to families 
            and patients suffering from NF and provide additional support 
            of essential research.

           FISCAL EFFECT  :  None
           

          Analysis Prepared by  :  Nicole Willis / RLS. / (916) 319-2800 









                                                                  ACR 51
                                                                  Page  2


                                                                FN: 0001454